opioid abuse

The three finalists of the RWJF's AI Challenge pose together on stage at Health 2.0
By Dave Muoio September 19, 2018
The victors of two Robert Wood Johnson Foundation (RWJF) pitch competitions were recently announced following a live judging session held at Health 2.0 in Santa Clara, California. There, judges named Buoy Health’s chatbot for patient health education the winner of RWJF’s AI Challenge, while social addiction support platform Sober Grid claimed first prize in the organization’s Opioid Challenge....
By Dave Muoio September 13, 2018
Following in the footsteps of its parent company, Instagram is looking reduce its potential role in the ongoing opioid epidemic. Whenever a user searches a drug or substance-related term on the platform, they will now be served a popup that includes a link to addiction and drug misuse resources. Should users click through the popup alert, Instagram redirects to a webpage asking users whether they...
By Laura Lovett May 23, 2018
A bipartisan group of senators has introduced a slew of new bills that seek to increase access to telemedicine treatment for patients with substance abuse disorders. The proposed bills, three of which are telehealth-focused, are expected to be wrapped into a larger legislative package by the Senate Finance Committee and then undergo the markup process in the near future.  “While South Dakota is...
By Jonah Comstock April 26, 2018
This Saturday, the United States Drug Enforcement Agency (DEA) will host its third National Prescription Drug Take Back Day. And this time, Google is helping out.  The search engine company and tech giant announced in a blog post yesterday that it would implement several features to support the DEA's efforts to combat the opioid crisis, starting with a Google Maps-based locator tool to help...
By Dave Muoio February 9, 2018
Rockville, Maryland-based DrFirst, which is known for healthcare SaaS offerings ranging from medication management to clinical communications, has announced a relaunch of a mobile app designed to help physicians comply with state prescription drug monitoring program requirements when prescribing treatments. DrFirst acquired the original iPrescribe.net app back in early 2016, shortly after...
By Dave Muoio January 10, 2018
Opioid abuse is among the most pressing issues in healthcare, so it’s no surprise that the epidemic was a major topic of discussion at CES 2018’s Digital Health Summit. Following a lengthy discussion about the national crisis’ societal factors and specific digital-based interventions, a panel comprised of industry experts and academics repeatedly found themselves in agreement that no one approach...
By Jonah Comstock December 11, 2017
Last week, the HHS' opioid crisis code-a-thon concluded with presentations by nine of the 50 teams that participated. Three of these teams were chosen as the competition's winners, and will receive $10,000 to further develop their ideas. “When the government holds a code-a-thon, there’s an admission in society that we have hit a roadblock, that we need help, and we go out to the polity to help us...
By Dave Muoio November 21, 2017
Opioid adherence remains a hot topic in healthcare amidst the US ongoing epidemic, and a solution may lie within the pills themselves. In a study recently published in Anesthesia & Analgesia, researchers testing eTectRx’s digital pill technology could allow practitioners to better understand patient opioid adherence, thereby paving the way to more appropriate dosage and use of the drugs. “We’...
By Dave Muoio October 26, 2017
As an opioid epidemic continues to threaten the US, the government is looking to its tech-savvy citizens for support. Here at the Connected Health Conference in Boston, Department of Health and Human Services’ Chief Technology Officer Bruce Greenstein called for developers to participate in a government-sanctioned codeathon to devise a technological solution to the epidemic. “When the government...
By Heather Mack March 29, 2017
Many pharmaceutical companies are now turning to digital tools to improve medication adherence, augment clinical trials, or develop parallel therapies with digital health companies. Rare is the pharmaceutical company that wants to actively get people to stop taking their medication, but that’s exactly the aim of a new study launched by Purdue Pharmaceuticals, maker of the blockbuster and...